Edition:
United States

CytRx Corp (CYTR.A)

CYTR.A on American Stock Exchange

0.56USD
22 May 2019
Change (% chg)

-- (--)
Prev Close
$0.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
256
52-wk High
$1.35
52-wk Low
$0.41

About

CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. The Company is focused on the clinical development of aldoxorubicin, its modified version of the chemotherapeutic agent, doxorubicin. It is engaged in Phase III trials for aldoxorubicin as a therapy for patients with soft tissue... (more)

Overall

Beta: 2.34
Market Cap(Mil.): $69.25
Shares Outstanding(Mil.): 165.83
Dividend: --
Yield (%): --

Financials

  CYTR.A Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -0.41 -- --
ROI: -112.76 8.91 13.82
ROE: -214.05 10.05 15.24

Earnings vs. Estimates